Florida Gastroenterological Society
Florida Gastroenterological Society

Proton pump inhibitor use doubles risk for COVID-19

An independent, dose-response relationship was seen between proton pump inhibitor use and COVID-19 positivity and, according to a study published in the American Journal of Gastroenterology.“We found that PPI use, particularly twice-daily dosing, is associated with increased odds for reporting a positive COVID-19 test, even after accounting for a wide range of sociodemographic, lifestyle, and clinical variables,” Christopher V. Almario, MD, MSHPM, from the department of Medicine at Cedars-Sinai Medical Center in Los Angeles, told Healio Gastroenterology. “Our findingsRead More

Posted in News

FGS Login Portal